Mephenoxalone

Mephenoxalone

SCHEMBL4621926

COc1ccccc1OCC1CNC(=O)O1.COc1ccccc1OCC1CNC(=O)O1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.77
▸ SYK P43405 9/20 0.59
▸ ADRA2C P18825 1/20 0.56
▸ LMNA P02545 2/20 0.55
▸ MAOA P21397 1/20 0.55
▸ SLC6A2 P23975 1/20 0.55
▸ IRAK4 Q9NWZ3 2/20 0.54
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ MAPT P10636 1/20 0.48
▸ USP2 O75604 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ CHRNB4 P30926 1/20 0.46
▸ CHRNA3 P32297 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mephenoxalone SCHEMBL935967 1.00 PKM (0.77) PKMSYKADRA2CLMNAMAOA
Mephenoxalone SCHEMBL5392 1.00 PKM (0.77) PKMSYKADRA2CLMNAMAOA
Mephenoxalone SCHEMBL1061349 0.99 PKM (0.75) PKMSYKADRA2CLMNAMAOA
Mephenoxalone SCHEMBL22472152 0.99 PKM (0.75) PKMSYKADRA2CLMNAMAOA
Mephenoxalone SCHEMBL7938104 0.99 PKM (0.75) PKMSYKADRA2CLMNAMAOA
Mephenoxalone SCHEMBL7117835 0.99 PKM (0.75) PKMSYKADRA2CLMNAMAOA
Mephenoxalone SCHEMBL2175454 0.99 PKM (0.75) PKMSYKADRA2CLMNAMAOA
Mephenoxalone SCHEMBL6098064 0.99 PKM (0.75) PKMSYKADRA2CLMNAMAOA
Mephenoxalone SCHEMBL1969509 0.99 PKM (0.75) PKMSYKADRA2CLMNAMAOA
Mephenoxalone SCHEMBL6492968 0.97 PKM (0.73) PKMSYKADRA2CLMNAMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948643-A2 3-ALKYL-5- (4-ALKYL-5-OXO-TETRAHYDROFURAN-2-YL) PYRROLIDIN-2-ONE DERIVATIVES AS INTERMEDIATES IN THE SYNTHESIS OF RENIN INHIBITORS Novartis AG (CH) 2008-07-30 — — EP disclosed
WO-2007138381-A2 PHOSPHONATED OXAZOLIDINONES AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS TARGANTA THERAPEUTICS INC. (CA) 2007-12-06 — — WO disclosed
WO-2007045420-A2 3-ALKYL-5- (4-ALKYL-5-OXO-TETRAHYDROFUTRAN-2-YL) PYRROLIDIN-2-ONE DERIVATIVES AS INTERMEDIATES IN THE SYNTHESIS OF RENIN INHIBITORS NOVARTIS AG (CH) 2007-04-26 — — WO disclosed
EP-1144751-A2 SOIL-RESISTANT SPIN FINISH COMPOSITIONS 3M Innovative Properties Company (US) 2001-10-17 — — EP disclosed
WO-2000041500-A2 SOIL-RESISTANT SPIN FINISH COMPOSITIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2000-07-20 — — WO disclosed
Send feedback